Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (8 quarters reported)
$152M in Q4 2024 → $117M now. Hover for any quarter.
As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Bicara Therapeutics Inc | 46.6% | Trimmed 7.7% | 2,920,509 | $54.4M |
| Ceribell Inc | 46.1% | Unchanged | 2,205,661 | $53.8M |
| Contineum Therapeutics Inc | 7.3% | Unchanged | 638,158 | $8.56M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 7 quarters.
quarter ended September 30, 2026 · filed October 15, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Bicara Therapeutics Inc | Trimmed | −243,008 | −$4.52M | 46.6% |
quarter ended June 30, 2026 · filed July 22, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Bicara Therapeutics Inc | Trimmed | −6,992 | −$208K | 63.8% |
quarter ended March 31, 2026 · filed April 22, 2026
No position changes this quarter.
quarter ended December 31, 2025 · filed February 11, 2026
No position changes this quarter.
quarter ended September 30, 2025 · filed November 07, 2025
No position changes this quarter.
quarter ended June 30, 2025 · filed July 22, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Cargo Therapeutics Inc | Exited | −1,100,732 | −$4.48M | — |
quarter ended March 31, 2025 · filed May 13, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Cargo Therapeutics Inc | Trimmed | −1,000,000 | −$4.07M | 4.8% |
Loading...
